Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
97.903,81
-0,31%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Candel Therapeutics Inc (CADL) Candel Therapeutics Inc (CADL) Notizie

Candel Therapeutics Inc

CADL
9,0809
0,0909 (1,01%)
04 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/12/202422:01GLOBECandel Therapeutics Announces Closing of Public Offering and..
14/12/202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202423:30EDGAR2Form 8-K - Current report
13/12/202422:36EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/12/202405:00GLOBECandel Therapeutics Announces Pricing of Public Offering
12/12/202422:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/12/202422:51GLOBECandel Therapeutics Announces $80 Million Proposed Public..
11/12/202413:00GLOBECandel Therapeutics Announces CAN-2409 Achieved Primary..
07/12/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202415:17EDGAR2Form 144 - Report of proposed sale of securities
29/11/202415:15EDGAR2Form 144 - Report of proposed sale of securities
29/11/202415:12EDGAR2Form 144 - Report of proposed sale of securities
28/11/202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202421:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202414:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202414:15EDGAR2Form 8-K - Current report
14/11/202414:00GLOBECandel Therapeutics Reports Third Quarter 2024 Financial..
09/11/202402:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202414:00GLOBECandel Therapeutics to Present at Jefferies London..
05/11/202415:00GLOBECandel Therapeutics to Present Preclinical Data at SITC..
01/11/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202413:30EDGAR2Form 8-K - Current report
28/10/202413:00GLOBECandel Therapeutics Showcases Innovative Cancer Therapy..
15/10/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202415:00GLOBECandel Therapeutics to Present Preclinical Data on..
04/10/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202423:16EDGAR2Form 144 - Report of proposed sale of securities
13/9/202423:53EDGAR2Form 144 - Report of proposed sale of securities
03/9/202414:00GLOBECandel Therapeutics to Present at H.C. Wainwright 26th..
13/8/202414:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202414:15EDGAR2Form 8-K - Current report
13/8/202414:00GLOBECandel Therapeutics Reports Second Quarter 2024 Financial..
19/7/202414:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202414:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202414:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202414:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202413:32EDGAR2Form 144 - Report of proposed sale of securities
17/7/202413:31EDGAR2Form 144 - Report of proposed sale of securities
17/7/202413:29EDGAR2Form 144 - Report of proposed sale of securities
17/7/202413:27EDGAR2Form 144 - Report of proposed sale of securities
15/7/202414:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202414:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202414:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202414:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202413:38EDGAR2Form 144 - Report of proposed sale of securities
11/7/202413:37EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 8,99 Min: 8,77 Max: 9,29
Chiusura: 8,99

La tua Cronologia

NASDAQ
CADL
Candel Therapeutics
TG
A1ZY94
Commonwealth of Australia
TG
RUMA
Republic of Romania
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network